An efficient mammalian transfer RNA target for bleomycin.

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• The antitumor antibiotic bleomycin is traditionally thought to function by cleaving DNA.
• Emerging evidence suggests RNA cleavage might also contribute to bleomycin's therapeutic effects.
• Specific transfer RNA (tRNA) molecules may be key targets for bleomycin action.

Purpose of the Study:

• To identify specific tRNA isoacceptors in chicken liver that are most vulnerable to bleomycin-induced oxidative cleavage.
• To elucidate the precise sites of cleavage on susceptible tRNAs.
• To investigate the influence of magnesium ions on the cleavage process.

Main Methods:

• Fractionation of chicken liver tRNAs to isolate different isoacceptors.
• Treatment of isolated tRNAs with Fe(II).BLM (iron(II)-bleomycin complex) to induce oxidative cleavage.
• Identification of cleavage sites on the tRNA molecules, particularly at nucleotide U66.
• Assessment of the effect of physiological magnesium concentrations on tRNA cleavage.

Main Results:

• Two chicken liver tRNAs, tRNA3Lys and tRNAPhe, were identified as highly susceptible to Fe(II).BLM cleavage.
• Cleavage predominantly occurred at the U66 position in both identified tRNAs.
• The cleavage of tRNA3Lys was largely unaffected by physiological concentrations of Mg2+.
• Chicken liver tRNA3Lys shares an identical sequence with human tRNA3Lys.

Conclusions:

• Specific tRNAs, notably tRNA3Lys, are critical targets for bleomycin-mediated cleavage.
• The findings suggest a significant role for tRNA3Lys in the antitumor mechanism of bleomycin.
• This research provides a molecular basis for understanding bleomycin's action beyond DNA, highlighting RNA's involvement.